DNA hydrogel-delivered hypoxic exosomes alleviate radiation-induced skin injury by stabilizing AKT.
Yin Q., Deng S., Liu Y., Luo H., Yuan S., Fei Y.
Animal Study, published in J Nanobiotechnology (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- J Nanobiotechnology (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42271440
- DOI
- 10.1186/s12951-026-04653-2
Abstract (original English)
Radiation-induced skin injury (RISI) is a common and refractory complication during tumor radiotherapy, characterized by radiation stress-induced impairment of keratinocyte viability and regenerative signaling, ultimately leading to delayed skin repair. Recently, hypoxia-preconditioned adipose-derived stem cell-derived exosomes (A-Hexos), a cell-free therapeutic strategy with favorable biocompatibility, has considerable potential in skin injury repair. However, the underlying mechanisms of A-Hexos in the treatment of RISI have not been fully elucidated, and their delivery efficiency and retention capacity at skin injury sites remain suboptimal. In this study, we aimed to enhance the targeted delivery efficiency of exosomes in skin tissues, systematically evaluate the therapeutic effects of A-Hexos in RISI repair, and elucidate the underlying molecular mechanisms. In vitro experiments demonstrated that A-Hexos significantly restored the viability, proliferative capacity, and migratory behavior of irradiated keratinocytes (HaCaT). To enhance the local delivery efficiency and tissue retention of exosomes at injured sites in vivo, we constructed a DNA hydrogel-based delivery system loaded with A-Hexos (Gel@A-Hexos), which was engineered through the specific interaction between an exosome membrane protein-specific aptamer (Apt CD63) designed on long DNA strands and the exosomal memb
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.